Tune in on 29 September for a special event featuring experts on #precisionmedicine approaches in immune-mediated diseases + a special announcement from Johnson & Johnson Innovation for #innovators in immunology jji.jnj/PrecisionMed #mycompany

Our webinar on EU grants is happening on Thursday. Do you want to about the experiences of startups in getting non-dilutive funding? Innovators are welcome to join. jji.jnj/3meVyxs #mycompany

Attention UK-based innovators! 🇬🇧 We are looking to connect with start-ups, entrepreneurs and researchers in the pharmaceutical, medical devices and consumer health fields. If this is you, tune in on 30 November to learn how we could work together. 👉 jji.jnj/meetintheuk

Excited for this program taking place on Thursday. It was inspiring to discuss the content with the speakers. #mycompany

The first release of Whole Genome Sequencing data for 200,000 UK Biobank participants is now available. We expect the data will enable a better understanding of the genetic determinants of disease and contribute to accelerating drug discovery work: jji.jnj/3kMCarJ

Great to see UMC Utrecht from my home town as one of the IDEA #QuickFireChallenge awardees aiming to optimize AL Amyloidosis disease detection: jji.jnj/IDEA #MyCompany

An organization will never change if the people don't change. To learn more I followed Prosci training on change management. It was great to learn more about the people side of change. credly.com/badges/46c1c7e…

Building a stellar team can be a key ingredient of success next to your disruptive invention and fitting funding. #mycompany

Have you identified your long-term exit strategy? Learn more during this hybrid seminar. #mycompany

We cultivate the European life sciences innovation ecosystem, aiming to enable entrepreneurs to create transformational healthcare solutions. To celebrate our collaborations, we’ve put the spotlight on our innovation network in EMEA. See more: jji.jnj/3wouRf3

#JLABS Global Head Melinda Richter joins Nasdaq Breakthrough Economy to discuss why inclusive access to capital is critical for life science innovation. Watch Melinda here: bit.ly/3E1CJsi

Onze oude woning in Lombok (Utrecht) is binnenkort te huur (nee, niet dat hutje op de foto ...). Er zit dan een nieuwe keuken in en de tuin (wel op de foto) blijft fantastisch. Geïnteresseerd!? 123wonen.nl/huur/utrecht/b…

Are you joining us in Leiden in two weeks' time? I believe this will be a very interesting discussion. #mycompany

It was great to be at Noviotech Campus to create this video. Nijmegen still feels a bit like home. Protinhi, thanks for being a part of this Johnson & Johnson Innovation JLABS initiative! #mycompany Briskr

Today at the Innovation for Health Global Investor Forum in Rotterdam, Maria Van Dongen and I provided a workshop on Business Development Basics, during which I also introduced Johnson & Johnson Innovation JLABS. Are you interested to discuss collaboration? Let me know! #mycompany #startups

Interested in collaboration? This program discusses the role of IP in collaborations such as multi-component cellular therapies and vaccines. Will you join me in Leiden? #MyCompany

Entrepreneurs and innovators are invited for an in-depth look into different aspects in the journey towards filing a #clinicaltrial application for large molecules. Will you join us in Leiden? #mycompany

Interested in a collaboration with J&J? Join this program to learn more about the due diligence process. #mycompany

So much of healthcare today is about connecting with the right stakeholders at the right time. Erik will be a keynote speaker during next week's JLABS program focused on the strategic use of Target Product Profiles. #mycompany

Calling the next generation of start-up CEOs! Interested in transforming your scientific innovation into a thriving biotech venture? Join a stellar line-up of speakers (and me) in Amsterdam! #mycompany